Immuneering (IMRX) Short Interest Ratio & Short Volume → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free IMRX Stock Alerts $1.57 -0.03 (-1.88%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Immuneering Short Interest DataCurrent Short Volume3,210,000 sharesPrevious Short Volume2,730,000 sharesChange Vs. Previous Month+17.58%Dollar Volume Sold Short$4.56 millionShort Interest Ratio / Days to Cover4.3Last Record DateApril 30, 2024Outstanding Shares29,650,000 sharesFloat Size20,890,000 sharesShort Percent of Float15.37%Today's Trading Volume106,293 sharesAverage Trading Volume531,234 sharesToday's Volume Vs. Average20% Short Selling Immuneering ? Sign up to receive the latest short interest report for Immuneering and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMRX Short Interest Over TimeIMRX Days to Cover Over TimeIMRX Percentage of Float Shorted Over Time Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company Immuneering Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,210,000 shares $4.56 million +17.6%15.4%4.3 $1.42 4/15/20242,730,000 shares $5.23 million -5.2%13.2%4 $1.92 3/31/20242,880,000 shares $8.32 million +10.3%14.0%4.8 $2.89 3/15/20242,610,000 shares $4.99 million -2.6%12.4%5.1 $1.91 2/29/20242,680,000 shares $16.62 million -0.7%12.6%40.4 $6.20 2/15/20242,700,000 shares $18.09 million +1.1%12.7%47.3 $6.70 Get the Latest News and Ratings for IMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,670,000 shares $15.67 million +1.1%12.6%42.4 $5.87 1/15/20242,640,000 shares $17.42 million +0.4%12.5%40.2 $6.60 12/31/20232,630,000 shares $19.33 million +3.5%12.4%39.6 $7.35 12/15/20232,540,000 shares $20.32 million -1.2%12.0%39.3 $8.00 11/30/20232,570,000 shares $16.86 million -6.9%12.1%43 $6.56 11/15/20232,760,000 shares $14.57 million -1.1%13.0%48.4 $5.28 10/31/20232,790,000 shares $19.61 million +1.8%13.2%58.2 $7.03 10/15/20232,740,000 shares $16.44 million -1.1%12.9%55.5 $6.00 9/30/20232,770,000 shares $21.27 million -2.5%13.1%54.7 $7.68 9/15/20232,840,000 shares $22.86 million +1.4%13.4%47.3 $8.05 8/31/20232,800,000 shares $25.23 million No Change13.2%27.5 $9.01 8/15/20232,800,000 shares $26.29 million +5.3%13.2%25.2 $9.39 7/31/20232,660,000 shares $27.03 million -0.8%12.6%23.6 $10.16 7/15/20232,680,000 shares $26.53 million +0.4%12.7%23 $9.90 6/30/20232,670,000 shares $27.07 million +35.5%12.6%21.7 $10.14 6/15/20231,970,000 shares $19.40 million +8.2%9.3%16.4 $9.85 5/31/20231,820,000 shares $14.11 million +15.9%8.6%23.9 $7.75 5/15/20231,570,000 shares $12.53 million +25.6%7.4%24 $7.98 4/30/20231,250,000 shares $13.73 million +23.8%6.3%19.5 $10.98 4/15/20231,010,000 shares $12.71 million +6.1%5.0%17.8 $12.58 3/31/2023951,600 shares $9.24 million +10.2%5.0%19.7 $9.71 3/15/2023863,500 shares $6.71 million +4.1%4.5%19.5 $7.77 2/28/2023829,300 shares $4.06 million +0.2%4.3%20.5 $4.89 2/15/2023828,000 shares $3.52 million -0.6%4.3%20.5 $4.25 1/31/2023832,900 shares $3.49 million -2.9%4.3%19 $4.19 1/15/2023857,900 shares $3.80 million -1.6%4.5%21.4 $4.43 12/30/2022871,800 shares $4.23 million -1.2%4.6%19.2 $4.85 12/15/2022882,600 shares $4.03 million +7.0%4.6%16.9 $4.57 11/30/2022825,200 shares $5.36 million +6.2%4.3%15.2 $6.49 11/15/2022776,800 shares $5.62 million -6.0%4.1%14.3 $7.24 10/31/2022826,200 shares $11.44 million +1.6%4.3%16.6 $13.85 10/15/2022813,500 shares $10.46 million +0.9%4.2%17.5 $12.86 9/30/2022806,000 shares $11.54 million +9.1%4.2%18.7 $14.32 9/15/2022738,600 shares $8.86 million -2.5%3.9%10.6 $11.99Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge IMRX Short Interest - Frequently Asked Questions What is Immuneering's current short interest? Short interest is the volume of Immuneering shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,210,000 shares of IMRX short. 15.37% of Immuneering's shares are currently sold short. Learn More on Immuneering's current short interest. What is a good short interest ratio for Immuneering? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMRX shares currently have a short interest ratio of 4.0. Learn More on Immuneering's short interest ratio. What is a good short interest percentage for Immuneering? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.37% of Immuneering's floating shares are currently sold short. Is Immuneering's short interest increasing or decreasing? Immuneering saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,210,000 shares, an increase of 17.6% from the previous total of 2,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Immuneering's float size? Immuneering currently has issued a total of 29,650,000 shares. Some of Immuneering's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immuneering currently has a public float of 20,890,000 shares. How does Immuneering's short interest compare to its competitors? 15.37% of Immuneering's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Immuneering: Aadi Bioscience, Inc. (6.50%), Clene Inc. (0.53%), Rockwell Medical, Inc. (2.13%), Bolt Biotherapeutics, Inc. (8.80%), NextCure, Inc. (0.53%), Reviva Pharmaceuticals Holdings, Inc. (4.48%), Ocuphire Pharma, Inc. (4.71%), HCW Biologics Inc. (0.05%), BioLineRx Ltd. (0.51%), Gain Therapeutics, Inc. (1.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Immuneering stock? Short selling IMRX is an investing strategy that aims to generate trading profit from Immuneering as its price is falling. IMRX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immuneering? A short squeeze for Immuneering occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMRX, which in turn drives the price of the stock up even further. How often is Immuneering's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Aadi Bioscience Short Interest Clene Short Interest Rockwell Medical Short Interest Bolt Biotherapeutics Short Interest NextCure Short Interest Reviva Pharmaceuticals Short Interest Ocuphire Pharma Short Interest HCW Biologics Short Interest BioLineRx Short Interest Gain Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMRX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsDems have chosen Biden replacement?Paradigm Press